• Product Modification Summary: Derived Block Eligibility and Decrease of the Minimum Price Increment for E-mini Nasdaq Biotechnology Index Futures for Transactions Submitted for Clearing via CME ClearPort - Effective August 08, 2022

      • To
      • Clearing Member Firms; Back Office Managers
      • From
      • CME Clearing
      • #
      • 22-265
      • Notice Date
      • 12 July 2022
      • Effective Date
      • 08 August 2022

    • Derived Block Eligibility and Decrease of the Minimum Price Increment for E-mini Nasdaq Biotechnology Index Futures for Transactions Submitted for Clearing via CME ClearPort.

      For the full text of this advisory, please click here.

       

CME Group is the world’s leading derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). 
Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.

© 2025 CME Group Inc. All rights reserved.